Evaluation of systemic impact of tricuspid regurgitation:an appeal for the notion of tricuspid regurgitation syndrome

作     者：Fanglin Lu Tianyuan Xiong Mao Chen 

作者机构：Department of Cardiovascular SurgeryChanghai HospitalSecond Military Medical UniversityShanghai 200433China Department of CardiologyWest China HospitalSichuan UniversityChengduSichuan 610041China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2023年第136卷第2期

页      面：138-140页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：supported by the National Natural Science Foundation of China(Nos.81970325 and 82102129) 

主　　题：mortality regurgitation impaired 

摘      要：Tricuspid regurgitation(TR)is an often encountered but undertreated valvular heart *** left-sided valvular diseases,it is estimated that only 5%of patients with significant TR were treated surgically,among which 86%were treated in combination with other major procedures.[1]This unmet need partially resulted from the lack of prospective evidence on reduced mortality of severe TR benefiting from surgery,alongside a historical viewpoint that functional TR(being the etiology for the vast majority of TR)would be improved once problems in the left heart are ***,untreated severe TR shows various symptoms and a poor prognosis,including increased early and late mortality and impaired quality of life.[2]With the rapid development of catheter-based valve therapies,less invasive treatment options have been offered to the once forgotten tricuspid valve,further expanding the complexity of decision-making for TR intervention.